Bacteriophages suppress CRISPR-Cas immunity using RNA-based anti-CRISPRs.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37853129.
- Also identified by DOI 10.1038/s41586-023-06612-5 and PMC identifier 10651486.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Many bacteria use CRISPR-Cas systems to combat mobile genetic elements, such as bacteriophages and plasmids<sup>1</sup>. In turn, these invasive elements have evolved anti-CRISPR proteins to block host immunity<sup>2,3</sup>. Here we unveil a distinct type of CRISPR-Cas Inhibition strategy that is based on small non-coding RNA anti-CRISPRs (Racrs). Racrs mimic the repeats found in CRISPR arrays and are encoded in viral genomes as solitary repeat units<sup>4</sup>. We show that a prophage-encoded Racr strongly inhibits the type I-F CRISPR-Cas system by interacting specifically with Cas6f and Cas7f, resulting in the formation of an aberrant Cas subcomplex. We identified Racr candidates for almost all CRISPR-Cas types encoded by a diverse range of viruses and plasmids, often in the genetic context of other anti-CRISPR genes<sup>5</sup>. Functional testing of nine candidates spanning the two CRISPR-Cas classes confirmed their strong immune inhibitory function. Our results demonstrate that molecular mimicry of CRISPR repeats is a widespread anti-CRISPR strategy, which opens the door to potential biotechnological applications<sup>6</sup>.
Medical subject headings
- Bacteria
- Bacteriophages
- CRISPR-Cas Systems
- Molecular Mimicry
- RNA, Viral